Pharmaceutical Research

U.S. researchers evaluate clinical response, safety and time to improvement with high-dose oral vitamin D for toxic erythema of chemotherapy and acute radiation dermatitis.

A study from Swedish researchers has found that reversing nivolumab and ipilimumab dose amounts improved survival rates, while reducing treatment-related toxicity.

There is no vaccine or treatment for the Bundibugyo type of Ebola, which has killed more than 1,700 people in Congo.

Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can target the protein have failed.

Systematic review and network meta-analysis of randomized clinical trials compares the efficacy and tolerability of topical treatments for moderate to severe rosacea. 

Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a blood test can detect tiny amounts of cancer remaining after patients have been treated.

The federal regulator is reviewing drug's approval after concerns emerge over integrity of clinical trial data.

Large scale study evaluates the association between glucagon-like peptide-1 (GLP-1) receptor agonist use and smell and taste disturbances.